1. Home
  2. REAL vs VYGR Comparison

REAL vs VYGR Comparison

Compare REAL & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$15.49

Market Cap

1.7B

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.93

Market Cap

226.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
VYGR
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
226.8M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
REAL
VYGR
Price
$15.49
$3.93
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$15.71
$17.00
AVG Volume (30 Days)
2.5M
407.9K
Earning Date
02-19-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$662,789,000.00
$31,316,000.00
Revenue This Year
$17.10
N/A
Revenue Next Year
$10.90
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
14.30
N/A
52 Week Low
$4.61
$2.65
52 Week High
$16.74
$6.27

Technical Indicators

Market Signals
Indicator
REAL
VYGR
Relative Strength Index (RSI) 57.80 41.76
Support Level $15.81 $3.93
Resistance Level $16.74 $4.26
Average True Range (ATR) 0.78 0.20
MACD -0.02 -0.03
Stochastic Oscillator 55.15 15.13

Price Performance

Historical Comparison
REAL
VYGR

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: